The SCRC understands the importance of early-stage clinical trials in bringing innovative treatments to the forefront and is in the process of establishing a Phase 1 unit. 

Soroka medical center established a special facilitated pathway in collaboration with the ethics committee to ensure the swift initiation of approved trials. This expedited process aims to streamline the necessary approvals, allowing researchers to begin their clinical trials promptly and efficiently. Our commitment to prioritizing patient well-being and advancing medical knowledge drives us to continually improve and expedite the trial initiation process.

Collaboration and partnership: We welcome collaborations with pharmaceutical companies, biotech firms, and academic institutions to accelerate the development of promising new treatments.